Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Oncothyreon (ONTY) Catches Eye: Stock Moves 11.6% Higher

Oncothyreon Inc ONTY was a big mover last session, as its shares rose almost 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally breaks the recent trend for the company, as the stock is now trading above the volatile price range of $1.11 to $1.27 in the past one-month time frame.

Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Oncothyreon currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked biomedical stock is Anika Therapeutics Inc. ANIK with a Zacks Rank #2 (Buy).

Is ONTY going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ANIKA THERAPEUT (ANIK): Free Stock Analysis Report
 
ONCOTHYREON INC (ONTY): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research